"10.1371_journal.pone.0100478","plos one","2014-06-23T00:00:00Z","Paolo Verdecchia; Fabio Angeli; Gregory Y H Lip; Gianpaolo Reboldi","Department of Medicine, Hospital of Assisi, Assisi, Italy; Cardiology and Cardiovascular Pathophysiology, University Hospital of Perugia, Perugia, Italy; University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom; Department of Medicine, University of Perugia, Perugia, Italy","Conceived and designed the experiments: PV FA GYHL GR. Analyzed the data: PV FA GYHL GR. Contributed reagents/materials/analysis tools: PV FA GYHL GR. Wrote the paper: PV FA GYHL GR.","This work has not been supported from any Pharmaceutical Company. PV has no conflict of interest to declare; FA has no conflict of interest to declare; GHL has served as a consultant for Bayer, Astellas, Merck, AstraZeneca, Sanofi, BMS/Pfizer, Biotronik, Portola and Boehringer Ingelheim and has been on the speakers bureau for Bayer, BMS/Pfizer, Boehringer Ingelheim, and Sanofi-Aventis; GR has no conflict of interest to declare. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","06","Paolo Verdecchia","PV",4,TRUE,4,NA,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
